SCHEDULE 13G/A: Irenic Capital Management Divests Entire Stake in Definitive Healthcare Corp., Filing Amended 13G Showing Zero Ownership

Irenic Capital Management LP and its affiliates have filed an amended Schedule 13G, indicating they no longer hold any beneficial ownership in Definitive Healthcare Corp.'s Class A Common Stock.

Summary

• Irenic Capital Management LP, along with Irenic Capital Evergreen Master Fund LP, Adam Katz, and Andrew Dodge, have filed an Amendment No. 1 to their Schedule 13G regarding Definitive Healthcare Corp.
• The filing reports that as of March 31, 2025, the reporting persons collectively hold 0.00 shares of Class A Common Stock, representing 0% of the class.
• This amendment signifies a complete divestment of their previously held stake in Definitive Healthcare Corp.
• The filing states that the securities were acquired and held in the ordinary course of business and not for the purpose of changing or influencing control, 'other than activities solely in connection with a nomination under §§ 240.14a-11', implying prior engagement in corporate governance matters despite the current zero ownership.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the complete divestment of shares by an institutional investor, which can signal a lack of confidence in the company's future performance or strategy.

Negatives

• Irenic Capital Management LP and its affiliates have fully divested their stake in Definitive Healthcare Corp., indicating a loss of institutional investor support.
• The reduction of beneficial ownership to 0% by a previously engaged investor could be perceived negatively by the market.

Risks

• Loss of institutional investor confidence as evidenced by the complete divestment.
• Potential negative signal to other investors, possibly leading to downward pressure on the stock price.
• Reduced oversight or advocacy from an active institutional shareholder.

Future Outlook

NA

Industry Context

This filing is specific to an investor's position and does not provide direct insights into broader industry trends or competitor performance within the healthcare technology sector. However, a significant institutional divestment could reflect a specific investor's view on the company's prospects within its industry.

Stakeholder Impact

• Shareholders: May view the divestment negatively, potentially leading to decreased investor confidence and downward pressure on the stock price.
• Company Management: Could face questions regarding the reasons for the institutional investor's exit and its implications for future capital attraction.

Key Dates

Recommendation

Keywords

Definitive Healthcare Corp., Irenic Capital Management, Schedule 13G, Beneficial Ownership, Stock Divestment, Institutional Investor, Healthcare Technology, DH, 24477E103